African Trials Moving Ahead with Great Success

Our vaccine is currently being tested for safety, tolerability and efficacy in Mali (West Africa) and Tanzania (East Africa). Both studies are in healthy adults, all of them self-selected individuals who have volunteered to participate in clinical research according to their interest in contributing to the development of an effective vaccine.

Many of the study subjects have experienced firsthand the devastating effects of malaria in their home villages, and all of them know that malaria is a major public health problem in their country.

African Collaborators

The study in Mali is being performed by the Malaria Research and Training Center, University of Bamako, in a village called Doneguebougou, in collaboration with the US National Institutes of Health Laboratory for Malaria Immunology and Vaccinology. The study in Tanzania is being done by the Ifakara Health Institute in Bagamoyo, in a collaboration with the Swiss Tropical and Public Health Institute.

In both studies, Sanaria is supplying and preparing the vaccine, which is being given by direct venous inoculation into the arm after transport to Africa in tanks of liquid nitrogen vapor phase to keep the sporozoites frozen until ready for injection.